Trials / Terminated
TerminatedNCT01568086
Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A
Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD03 Applied During AFFiRiS 005A
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 16 (actual)
- Sponsor
- Affiris AG · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase Ib follow-up study to evaluate long-term safety and tolerability of immunization with AFFITOPE AD03 applied during AFFiRiS 005A.
Conditions
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2013-06-01
- Completion
- 2013-10-01
- First posted
- 2012-04-02
- Last updated
- 2013-11-06
Locations
2 sites across 1 country: Austria
Source: ClinicalTrials.gov record NCT01568086. Inclusion in this directory is not an endorsement.